Table 5. EQ-5D-3L and quality adjusted life-years; complete cases.
| Timepoint | EQ-5D-5L complete cases | Quality adjusted life-years complete cases | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intravenous | Oral | Intravenous | Oral | |||||||||
| Mean
(SD) |
N (%) | Mean
(SD) |
N (%) | Difference
(SE) ‡ |
95%
confidence interval |
Mean
(SD) |
N (%) | Mean
(SD) |
N (%) | Difference
(SE) ‡ |
95%
confidence interval |
|
| Baseline | 0.298
(0.363) |
386
(73.2%) |
0.330
(0.379) |
388
(73.6%) |
-0.032
(0.027) |
-0.085 to 0.020 | ||||||
| 14 days | 0.437
(0.304) |
308
(58.4%) |
0.421
(0.338) |
309
(58.6%) |
0.016
(0.026) |
-0.035 to 0.067 | 0.014
(0.011) |
297
(56.3%) |
0.014
(0.012) |
300
(56.9%) |
-0.0001
(0.0009) |
-0.0020 to 0.0017) |
| 42 days | 0.513
(0.316) |
366
(69.4%) |
0.531
(0.330) |
374
(71.0%) |
-0.018
(0.024) |
-0.064 to 0.029 | 0.037
(0.022) |
265
(50.3%) |
0.037
(0.023) |
274
(52.0%) |
-0.0002
(0.0019) |
-0.0039 to 0.0036 |
| 120 days | 0.534
(0.337) |
312
(59.2%) |
0.544
(0.354) |
306
(58.1%) |
-0.011
(0.028) |
-0.065 to 0.044 | 0.111
(0.063) |
280
(53.1%) |
0.116
(0.064) |
279
(52.9%) |
-0.0045
(0.0054) |
-0.0150 to 0.0060 |
| 365 days | 0.564
(0.339) |
301
(57.1%) |
0.576
(0.346) |
286
(54.3%) |
-0.016
(0.028) |
-0.067 to 0.044 | 0.365
(0.200) |
224
(46.3%) |
0.365
(0.213) |
228
(43.3%) |
-0.0003
(0.0191) |
-0.0378 to 0.0372 |
| Total year | 0.558
(0.265) |
179
(34.0%) |
0.535
(0.300) |
182
(31.8%) |
0.023
(0.030) |
-0.036 to 0.081 | ||||||
SD, standard deviation; N, number; SE, standard error.
‡Difference between arms was calculated using t-tests